|
1
|
Ferlay J, Colombet M, Soerjomataram I,
Mathers C, Parkin DM, Piñeros M, Znaor A and Bray F: Estimating the
global cancer incidence and mortality in 2018: GLOBOCAN sources and
methods. Int J Cancer. 144:1941–1953. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Blattner M, Lee DJ, O'Reilly C, Park K,
MacDonald TY, Khani F, Turner KR, Chiu YL, Wild PJ, Dolgalev I, et
al: SPOP mutations in prostate cancer across demographically
diverse patient cohorts. Neoplasia. 16:14–20. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
zur Hausen H: Human papillomaviruses and
their possible role in squamous cell carcinomas. Curr Top Microbiol
Immunol. 78:1–30. 1977.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Faridi R, Zahra A, Khan K and Idrees M:
Oncogenic potential of human papillomavirus (HPV) and its relation
with cervical cancer. Virol J. 8(269)2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Paavonen J, Naud P, Salmerón J, Wheeler
CM, Chow SN, Apter D, Kitchener H, Castellsagué X, Teixeira JC,
Skinner SR, et al: Efficacy of human papillomavirus (HPV)-16/18
AS04-adjuvanted vaccine against cervical infection and precancer
caused by oncogenic HPV types (PATRICIA): Final analysis of a
double-blind, randomised study in young women. Lancet. 374:301–314.
2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
McNicol PJ and Dodd JG: Detection of human
papillomavirus DNA in prostate gland tissue by using the polymerase
chain reaction amplification assay. J Clin Microbiol. 28:409–412.
1990.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chen AC, Waterboer T, Keleher A, Morrison
B, Jindal S, McMillan D, Nicol D, Gardiner RA, McMillan NA and
Antonsson A: Human papillomavirus in benign prostatic hyperplasia
and prostatic adenocarcinoma patients. Pathol Oncol Res.
17:613–617. 2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yang L, Xie S, Feng X, Chen Y, Zheng T,
Dai M, Zhou CK, Hu Z, Li N and Hang D: Worldwide prevalence of
human papillomavirus and relative risk of prostate cancer: A
meta-analysis. Sci Rep. 5(14667)2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ghasemian E, Monavari SH, Irajian GR,
Jalali Nodoshan MR, Roudsari RV and Yahyapour Y: Evaluation of
human papillomavirus infections in prostatic disease: A
cross-sectional study in Iran. Asian Pac J Cancer Prev.
14:3305–3308. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Bae JM: Human papillomavirus 16 infection
as a potential risk factor for prostate cancer: An adaptive
meta-analysis. Epidemiol Health. 37(e2015005)2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Lawson JS and Glenn WK: Evidence for a
causal role by mouse mammary tumour-like virus in human breast
cancer. NPJ Breast Cancer. 5(40)2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Resnick RM, Cornelissen MT, Wright DK,
Eichinger GH, Fox HS, ter Schegget J and Manos MM: Detection and
typing of human papillomavirus in archival cervical cancer
specimens by DNA amplification with consensus primers. J Natl
Cancer Inst. 82:1477–1484. 1990.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lee SH, Vigliotti VS, Vigliotti JS and
Pappu S: Validation of human papillomavirus genotyping by signature
DNA sequence analysis. BMC Clin Pathol. 9(3)2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wang Y, Holland JF, Bleiweiss IJ, Melana
S, Liu X, Pelisson I, Cantarella A, Stellrecht K, Mani S and Pogo
BG: Detection of mammary tumor virus env gene-like sequences in
human breast cancer. Cancer Res. 55:5173–5179. 1995.PubMed/NCBI
|
|
15
|
Ford CE, Tran D, Deng Y, Ta VT, Rawlinson
WD and Lawson JS: Mouse mammary tumor virus-like gene sequences in
breast tumors of Australian and Vietnamese women. Clin Cancer Res.
9:1118–1120. 2003.PubMed/NCBI
|
|
16
|
Medel-Flores O, Valenzuela-Rodríguez VA,
Ocadiz-Delgado R, Castro-Muñoz LJ, Hernández-Leyva S,
Lara-Hernández G, Silva-Escobedo JG, Vidal PG and Sánchez-Monroy V:
Association between HPV infection and prostate cancer in a Mexican
population. Genet Mol Biol. 41:781–789. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Dillner J, Knekt P, Boman J, Lehtinen M,
Af Geijersstam V, Sapp M, Schiller J, Maatela J and Aromaa A:
Sero-epidemiologal association between human-papillomavirus
infection and risk of prostate cancer. Int J Cancer. 75:564–567.
1998.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Tirosh O, Conlan S, Deming C, Lee-Lin SQ
and Huang X: NISC Comparative Sequencing Program. Su HC, Freeman
AF, Segre JA and Kong HH: Expanded skin virome in DOCK8-deficient
patients. Nat Med. 24:1815–1821. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Tsiagbe VK, Yoshimoto T, Asakawa J, Cho
SY, Meruelo D and Thorbecke GJ: Linkage of superantigen-like
stimulation of syngeneic T cells in a mouse model of follicular
center B cell lymphoma to transcription of endogenous mammary tumor
virus. EMBO J. 12:2313–2320. 1993.PubMed/NCBI
|
|
20
|
Sharma P and Schreiber-Agus N: Mouse
models of prostate cancer. Oncogene. 18:5349–5355. 1999.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kang JJ, Schwegel T and Knepper JE:
Sequence similarity between the long terminal repeat coding regions
of mammary-tumorigenic BALB/cV and renal-tumorigenic C3H-K strains
of mouse mammary tumor virus. Virology. 196:303–308.
1993.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Uz-Zaman T, Ignatowicz L and Sarkar NH:
Mouse mammary tumor viruses expressed by RIII/Sa mice with a high
incidence of mammary tumors interact with the Vbeta-2-and
Vbeta-8-specific T cells during viral infection. Virology.
314:294–304. 2003.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Moore R, Dixon M, Smith R, Peters G and
Dickson C: Complete nucleotide sequence of a milk-transmitted mouse
mammary tumor virus: Two frameshift suppression events are required
for translation of gag and pol. J Virol. 61:480–490.
1987.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Singh N, Josefsson A, Hussain S and
Hugosson J: Human papillomavirus (HPV) infection as an emerging
risk factor in prostate cancer. J Global Oncol. 4 (Suppl
2):2018.
|
